<?xml version='1.0' encoding='utf-8'?>
<document id="20705902"><sentence text="The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics."><entity charOffset="14-24" id="DDI-PubMed.20705902.s1.e0" text="paroxetine" /><entity charOffset="60-70" id="DDI-PubMed.20705902.s1.e1" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.20705902.s1.e0" e2="DDI-PubMed.20705902.s1.e0" /><pair ddi="false" e1="DDI-PubMed.20705902.s1.e0" e2="DDI-PubMed.20705902.s1.e1" /></sentence><sentence text="to assess the impact of paroxetine coadministration on the stereoselective pharmacokinetic (PK) properties of carvedilol"><entity charOffset="24-34" id="DDI-PubMed.20705902.s2.e0" text="paroxetine" /><entity charOffset="110-120" id="DDI-PubMed.20705902.s2.e1" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.20705902.s2.e0" e2="DDI-PubMed.20705902.s2.e0" /><pair ddi="false" e1="DDI-PubMed.20705902.s2.e0" e2="DDI-PubMed.20705902.s2.e1" /></sentence><sentence text="" /><sentence text="prospective, randomized, 2-phase crossover" /><sentence text="" /><sentence text="the University of Michigan General Clinical Research Unit and Michigan Clinical Research Unit" /><sentence text="" /><sentence text="twelve healthy volunteers aged 18 to 45 years, male and female, receiving no treatment with prescription or nonprescription medications" /><sentence text="" /><sentence text="participants received single dose oral carvedilol (12"><entity charOffset="39-49" id="DDI-PubMed.20705902.s10.e0" text="carvedilol" /></sentence><sentence text="5 mg) with and without coadministration of immediate-release paroxetine (10 mg orally twice daily), in random order"><entity charOffset="61-71" id="DDI-PubMed.20705902.s11.e0" text="paroxetine" /></sentence><sentence text=" Blood samples were collected at 0, 0" /><sentence text="25, 0" /><sentence text="5, 0" /><sentence text="75, 1, 1" /><sentence text="5, 2, 4, 6, 8, 10, 12, and 24 hours post-carvedilol dose for determination of R and S carvedilol plasma enantiomer concentrations by high pressure liquid chromatography"><entity charOffset="86-96" id="DDI-PubMed.20705902.s16.e0" text="carvedilol" /></sentence><sentence text="" /><sentence text="pharmacokinetic (PK) parameters were calculated for each enantiomer by noncompartmental methods and compared between study phases by analysis of variance (ANOVA) controlling for study phase order and subject, with Tukey's studentized range test post hoc" /><sentence text=" Area under the concentration-time curve (AUC) increased significantly with paroxetine coadministration, approximately 2"><entity charOffset="76-86" id="DDI-PubMed.20705902.s19.e0" text="paroxetine" /></sentence><sentence text="5-fold and 1" /><sentence text="9-fold for the R and S enantiomers, respectively" /><sentence text=" R/S AUC ratio increased significantly, from approximately 2" /><sentence text="3 to 3" /><sentence text="0" /><sentence text=" Individual increases in enantiomeric AUCs with paroxetine coadministration ranged from 0% to 571% and changes in R/S ratio ranged from -8% to 108%"><entity charOffset="48-58" id="DDI-PubMed.20705902.s25.e0" text="paroxetine" /></sentence><sentence text=" Heart rate, P-R interval, and blood pressure were monitored and no clinically significant changes in carvedilol effects were noted" /><sentence text="" /><sentence text="this study demonstrated a PK drug-drug interaction between paroxetine and carvedilol, with considerable interparticipant variability in carvedilol PK parameters and magnitude of drug interaction"><entity charOffset="59-69" id="DDI-PubMed.20705902.s28.e0" text="paroxetine" /><entity charOffset="74-84" id="DDI-PubMed.20705902.s28.e1" text="carvedilol" /><pair ddi="false" e1="DDI-PubMed.20705902.s28.e0" e2="DDI-PubMed.20705902.s28.e0" /><pair ddi="false" e1="DDI-PubMed.20705902.s28.e0" e2="DDI-PubMed.20705902.s28.e1" /></sentence><sentence text=" Stereoselectivity of carvedilol metabolism is preserved with paroxetine coadministration, and R/S AUC ratio generally widens"><entity charOffset="22-32" id="DDI-PubMed.20705902.s29.e0" text="carvedilol" /><entity charOffset="62-72" id="DDI-PubMed.20705902.s29.e1" text="paroxetine" /><pair ddi="false" e1="DDI-PubMed.20705902.s29.e0" e2="DDI-PubMed.20705902.s29.e0" /><pair ddi="false" e1="DDI-PubMed.20705902.s29.e0" e2="DDI-PubMed.20705902.s29.e1" /></sentence><sentence text=" Although this drug interaction could potentially increase adrenergic antagonism and have significant clinical effects in patients, these effects were not seen in our healthy volunteer participants" /><sentence text="" /></document>